Full List of Conditions and Traits
- Atrial fibrillation
- Benefit of using verapamil compared to atenolol | New!
- Blood pressure control on verapamil | New!
- Caffeine metabolism
- Clopidogrel metabolism
- Coronary artery disease
- Diabetes, type 1
- Diabetes, type 2
- Estrogen supplementation and risk of venous thrombosis
- Genetic risk for decreased folate
- Genetic risk for decreased HDL cholesterol
- Genetic risk for elevated LDL cholesterol
- Genetic risk for elevated triglycerides
- Heart rate and blood pressure response to metoprolol | New!
- Hypertension
- Myocardial infarction
- Peripheral arterial disease
- Sickle cell anemia
- Statin-induced myopathy
- Statin-therapeutic benefit
- Survival benefit on beta-blockers in heart failure patients | New!
- Therapeutic benefit of perindopril (ACE inhibitor) in stable coronary artery disease | New!
- Verapamil-induced QTc interval prolongation | New!
- Warfarin sensitivity
View the full list
- 3-Methylcrotonyl-CoA carboxylase deficiency
- Acrodermatitis enteropathica
- Alpha-1 antitrypsin deficiency
- Amyotrophic lateral sclerosis
- Argininosuccinate lyase deficiency
- Autoimmune polyglandular syndrome, type I
- Bartter syndrome, type 4A
- Beta-ketothiolase deficiency
- Beta-thalassemia
- Biotinidase deficiency
- Bloom syndrome
- Canavan disease
- Carnitine deficiency, primary systemic
- Cerebrotendinous xanthomatosis
- Citrullinemia, type I
- Corticosterone methyl oxidase deficiency
- Crigler-Najjar syndrome
- Cystic fibrosis
- Diabetes, permanent neonatal
- Dihydropyrimidine dehydrogenase deficiency
- Dubin-Johnson syndrome
- Ehlers-Danlos syndrome, dermatosparaxis
- Ehlers-Danlos syndrome, hypermobility
- Ehlers-Danlos syndrome, kyphoscoliotic
- Ethylmalonic aciduria
- Factor XI deficiency
- Familial dysautonomia
- Familial Mediterranean fever
- Fanconi anemia
- Galactokinase deficiency
- Galactosemia
- Gaucher disease
- Glutaric acidemia, type 1
- Glycogen storage disease, type 1A
- GM1-gangliosidosis
- Hearing loss, DFNB1 and DFNB9 nonsyndromic
- Hearing loss, DFNB59 nonsyndromic
- Hemochromatosis
- Hemoglobin C
- Hemoglobin E
- HMG-CoA lyase deficiency
- Homocystinuria, cblE type
- Homocystinuria, classic
- Hurler syndrome
- Krabbe disease
- Lipoprotein lipase deficiency, familial
- Maple syrup urine disease
- Medium-chain acyl-CoA dehydrogenase deficiency
- Methylmalonic acidemia
- MTHFR deficiency
- Mucolipidosis II
- Mucolipidosis III
- Mucolipidosis IV
- Multiple carboxylase deficiency
- Nephrotic syndrome, steroid-resistant
- Niemann-Pick disease
- Phenylketonuria
- Polycystic kidney disease
- Pompe disease
- Prekallikrein deficiency
- Propionic acidemia
- Prothrombin deficiency
- Rh-null syndrome
- Rickets, pseudovitamin D-deficiency
- Sandhoff disease
- Short-chain acyl-CoA dehydrogenase deficiency
- Sick sinus syndrome
- Sickle cell disease
- Spherocytosis, hereditary
- Tay-Sachs disease
- Tay-Sachs pseudodeficiency
- Thrombocytopenia, congenital amegakaryocytic
- Tyrosinemia
- Very long-chain acyl-CoA dehydrogenase deficiency
- Von Willebrand disease, type 2 Normandy
- Von Willebrand disease, type 3
View the full list
| Condition |
African |
Asian |
Caucasian |
Hispanic |
| Age-related macular degeneration |
|
 |
|
|
| Alzheimer’s disease, late onset |
|
|
|
|
| Amyotrophic lateral sclerosis |
|
|
|
|
| Asthma |
|
|
|
|
| Atrial fibrillation |
|
|
|
|
| Breast cancer (females only) |
|
|
|
|
| Colorectal cancer |
|
|
|
|
| Coronary artery disease |
|
|
|
|
| Diabetes, type 1 |
|
|
|
|
| Diabetes, type 2 |
|
|
|
|
| Exfoliation glaucoma |
|
|
|
|
| Hypertension |
|
|
|
|
| Leukemia, chronic lymphocytic |
|
|
|
|
| Lung cancer |
|
|
|
|
| Melanoma |
|
|
|
|
| Multiple sclerosis |
|
|
|
|
| Myocardial infarction |
|
|
|
|
| Obesity |
|
|
|
|
| Osteoarthritis |
|
|
|
|
| Parkinson’s disease |
|
|
|
|
| Peripheral arterial disease |
|
|
|
|
| Prostate cancer |
|
|
|
|
| Psoriasis |
|
|
|
|
| Rheumatoid arthritis |
|
|
|
|
| Systemic lupus erythematosus |
|
|
|
|
| Ulcerative colitis |
|
|
|
|
View the full list
Matching Diet
- Genetic risk for decreased omega-6 and omega-3
- Matching diet type
- Response to monounsaturated fats
- Response to polyunsaturated fats
Eating Behavior Traits
- Eating disinhibition
- Food desire
- Hunger
- Satiety - feeling full
- Snacking
- Sweet tooth
Food Reactions
- Alcohol flush
- Bitter taste
- Caffeine metabolism
- Lactose intolerance
- Sweet taste
Nutritional Needs
- Genetic risk due to decreased vitamin B2
- Genetic risk for decreased vitamin A
- Genetic risk for decreased vitamin B12
- Genetic risk for decreased vitamin B6
- Genetic risk for decreased vitamin C
- Genetic risk for decreased vitamin D
- Genetic risk for increased vitamin E
- Genetic risk for decreased folate
Exercise
- Achilles tendinopathy
- Aerobic capacity (VO2max)
- Blood pressure response to exercise
- BMI response to exercise
- Endurance training
- HDL cholesterol response to exercise
- Insulin sensitivity response to exercise
- Loss of body fat response to exercise
- Muscle power / sprinter gene
- Strength training
Your Body and Weight
- Genetic risk for decreased adiponectin
- Metabolism
- Obesity
- Weight loss-regain
Metabolic Health Factors
- Genetic risk for decreased HDL cholesterol
- Genetic risk for elevated blood sugar
- Genetic risk for elevated LDL cholesterol
- Genetic risk for elevated triglycerides
View the full list
- Abacavir hypersensitivity
- Aminoglycoside antibiotics-induced hearing loss
- Caffeine metabolism
- Carbamazepine hypersensitivity
- Clopidogrel metabolism
- Estrogen supplementation and risk of venous thrombosis (females only)
- Methotrexate toxicity in rheumatoid arthritis patients
- Statin - therapeutic benefit
- Statin-induced myopathy
- Warfarin sensitivity
View the full list
